Form 4: Director Janet Napolitano Receives Vir Biotechnology Equity

Director Janet Napolitano acquired 8,000 restricted stock units and 16,000 stock options as part of Vir Biotechnology's equity incentive plan.

Summary

• Director Janet Napolitano was granted 8,000 restricted stock units (RSUs) on May 27, 2026.
• The director also received a stock option grant for 16,000 shares with an exercise price of $9.10.
• Both the RSUs and the stock options are scheduled to vest in full on May 27, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine director compensation.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.
• Standard equity incentive grant indicates ongoing commitment from board leadership.

Negatives

• The grant results in potential future dilution for existing shareholders upon vesting and exercise.

Risks

• Market price volatility could impact the future value of the granted options.
• The exercise price of $9.10 is subject to market fluctuations relative to the company's future performance.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on director compensation.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practices in the biotechnology sector to ensure director retention and alignment with long-term clinical and commercial milestones.

Comparison to Industry Standards

• The grant structure is consistent with standard equity incentive plans for non-employee directors in mid-cap biotechnology firms.
• Vesting schedules of one year for director equity are common practice to ensure continued service.

Stakeholder Impact

• Shareholders may experience minor dilution upon the eventual exercise of options and vesting of RSUs.

Next Steps

• Vesting of RSUs and stock options on May 27, 2027.

Key Dates

Keywords

Vir Biotechnology, VIR, Form 4, Insider Trading, Equity Incentive Plan, Janet Napolitano